672 related articles for article (PubMed ID: 17266583)
1. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins.
Lahera V; Goicoechea M; de Vinuesa SG; Miana M; de las Heras N; Cachofeiro V; Luño J
Curr Med Chem; 2007; 14(2):243-8. PubMed ID: 17266583
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic effects of statins.
Liao JK; Laufs U
Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of statins in atherosclerosis: role on endothelial function, inflammation and immunomodulation.
Arnaud C; Mach F
Arch Mal Coeur Vaiss; 2005 Jun; 98(6):661-6. PubMed ID: 16007821
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications for statin pleiotropy.
Liao JK
Curr Opin Lipidol; 2005 Dec; 16(6):624-9. PubMed ID: 16276239
[TBL] [Abstract][Full Text] [Related]
5. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol.
Liao JK
Am J Cardiol; 2005 Sep; 96(5A):24F-33F. PubMed ID: 16126020
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis.
Arnaud C; Veillard NR; Mach F
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Apr; 5(2):127-34. PubMed ID: 15853754
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
Takemoto M; Liao JK
Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1712-9. PubMed ID: 11701455
[TBL] [Abstract][Full Text] [Related]
8. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
Danesh FR; Kanwar YS
FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
[TBL] [Abstract][Full Text] [Related]
9. Pleiotropic effects of statins and related pharmacological experimental approaches.
Alegret M; Silvestre JS
Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729
[TBL] [Abstract][Full Text] [Related]
10. Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction.
Ito MK; Talbert RL; Tsimikas S
Pharmacotherapy; 2006 Jul; 26(7 Pt 2):85S-97S; discussion 98S-101S; quiz 106S-108S. PubMed ID: 16803418
[TBL] [Abstract][Full Text] [Related]
11. Antioxidative effects of statins.
Adam O; Laufs U
Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762
[TBL] [Abstract][Full Text] [Related]
12. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy.
Zhou Q; Liao JK
Curr Pharm Des; 2009; 15(5):467-78. PubMed ID: 19199975
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic effects of statins--clinical evidence.
Athyros VG; Kakafika AI; Tziomalos K; Karagiannis A; Mikhailidis DP
Curr Pharm Des; 2009; 15(5):479-89. PubMed ID: 19199976
[TBL] [Abstract][Full Text] [Related]
14. Pleiotropic effects of statins and related pharmacological experimental approaches.
Alegret M; Silvestre JS
Timely Top Med Cardiovasc Dis; 2007 Apr; 11():E10. PubMed ID: 17473899
[TBL] [Abstract][Full Text] [Related]
15. Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.
Sawada N; Liao JK
Antioxid Redox Signal; 2014 Mar; 20(8):1251-67. PubMed ID: 23919640
[TBL] [Abstract][Full Text] [Related]
16. Beyond lipid-lowering: effects of statins on endothelial nitric oxide.
Laufs U
Eur J Clin Pharmacol; 2003 Mar; 58(11):719-31. PubMed ID: 12634978
[TBL] [Abstract][Full Text] [Related]
17. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.
Wang CY; Liu PY; Liao JK
Trends Mol Med; 2008 Jan; 14(1):37-44. PubMed ID: 18068482
[TBL] [Abstract][Full Text] [Related]
18. The pleiotropic effects of statins.
Calabrò P; Yeh ET
Curr Opin Cardiol; 2005 Nov; 20(6):541-6. PubMed ID: 16234628
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: candidate mechanisms for anti-lipid deposition in blood vessels.
Kumai T; Matsumoto N; Koitabashi Y; Takeba Y; Oonuma S; Sekine S; Tadokoro M; Kobayashi S
Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul; 3(3):195-201. PubMed ID: 15974884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
